GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -72.7% | 413 | -81.6% | 0.00% | -100.0% |
| Q4 2018 | $11,000 | +266.7% | 2,239 | +440.8% | 0.00% | +100.0% |
| Q3 2018 | $3,000 | +50.0% | 414 | +97.1% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | -100.0% | 210 | -69.5% | 0.00% | -50.0% |
| Q2 2017 | $8,000,000 | +33.3% | 689 | +40.6% | 0.00% | 0.0% |
| Q1 2017 | $6,000,000 | -40.0% | 490 | -41.7% | 0.00% | 0.0% |
| Q4 2016 | $10,000,000 | +99900.0% | 840 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $10,000 | – | 840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |